• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Low household income associated with worse outcomes for estrogen receptor-positive breast cancer

byAikansha ChawlaandAlex Chan
February 28, 2023
in Obstetrics, Oncology, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Low household income is associated with higher 21-gene recurrence scores (score based on gene expression signatures that indicated risk of distant metastasis) and significantly worse survival outcomes among those with scores below 26 for ER positive breast cancer.

2. Income levels not associated with surgical outcomes when 21-gene recurrence scores were 26 or higher.

Evidence Rating Level: 2 (Good)

Low socioeconomic status (SES) is a risk factor for unfavorable breast cancer outcomes. Previous studies have found that low income is associated with a higher incidence of triple negative breast cancer, however the relationship between low income and 21-gene recurrence score (RS) for patients with estrogen receptor (ER)-positive breast cancer is unknown. RS is a score based on gene expression signatures indicating the risk of distant metastasis, ranging from 0 to 100 with RS of 25 or below indicating non-high risk and RS above 25 indicating high risk. This observational cohort study evaluated the association of income levels with RS and overall survival (OS) for those with nonmetastatic ER-positive breast cancer. The study included 119 478 women, 68.8% of whom had high income (above the median household income of $50 353) and 31.2% had low income (below the median household income of $50 353). Compared to high income, low income was associated with a higher RS (adjusted odds ratio [aOR], 1.11; 95% CI, 1.06-1.16) and low income was also associated with worse OS (adjusted hazards ratio [aHR], 1.18; 95% CI, 1.11-1.25). For those with RS of 26 or higher, no significant OS differences were found between income levels. Limitations to this study include its retrospective nature, as certain relevant variables were unavailable for analysis. Additionally, only a small proportion of patients had high RS, and the subgroup analysis may have been inadequately powered to detect differences within the subgroup. Overall, this study indicates that low household income is associated with higher RS and worse survival outcomes among those with RS below 26. Future studies investigating various other social determinants of health and tumour biology may help provide further information on the various determinants of breast cancer outcomes.

Click to read the study in JAMA Network Open

Image: PD

RELATED REPORTS

Ivonescimab improves survival in advanced non-small cell lung cancer

Utilization of an early-life risk factor score to determine later life type 2 diabetes risk

Sotorasib plus panitumumab may be a promising treatment option for colorectal cancer

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Breast Canceroncologysocial determinants of health
Previous Post

Higher protein doses do not improve outcomes in mechanically ventilated patients with high nutritional risk

Next Post

The NICE-SUGAR trial: Intensive glycemic control harmful in the ICU [Classics Series]

RelatedReports

Lessons from real-world implementation of lung cancer screening
Chronic Disease

Ivonescimab improves survival in advanced non-small cell lung cancer

April 30, 2025
Intrapartum serum prolactin may predict risk of postpartum diabetes
Cardiology

Utilization of an early-life risk factor score to determine later life type 2 diabetes risk

April 29, 2025
Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs
Gastroenterology

Sotorasib plus panitumumab may be a promising treatment option for colorectal cancer

April 16, 2025
No difference in PET-CT surveillance versus planned neck dissection in advanced head and neck cancer
Cardiology

Genetic, clinical, lifestyle and sociodemographic risk factors for head and neck cancer:

April 13, 2025
Next Post
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]

The NICE-SUGAR trial: Intensive glycemic control harmful in the ICU [Classics Series]

Classics Series, Landmark Trials in Medicine

The POISE trial: Perioperative use of beta-blockers [Classics Series]

The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]

The Child-Pugh score: Prognosis in chronic liver disease and cirrhosis [Classics Series]

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
  • 2 Minute Medicine Rewind May 12, 2025
  • Self-perceived stress associated with increased risk of cryptogenic ischemic stroke
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.